Virco Bvba
Records under this name other than patents Virco Bvba holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,409,803 | Respiratory syncytial virus (RSV) viral load detection assay Formerly held Lapsed on the fee record Ended Apr 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 2, 2025 | From the USPTO record |
| US 8,945,833 | Method for Determining Drug Resistance Mutations in Any of the Non-Structural Protein Regions NS3 to NS5B of Hepatitis C Virus (HCV) for Genotypes 1 to 6 Lapsed on the fee record Ended Feb 3, 2023 · High confidence | Lapsed on the fee record | Ended Feb 3, 2023 | High confidence |
| US 7,235,387 | Method for mutation detection in HIV-1 using pol sequencing Formerly held Term ended Term ended May 16, 2021 · From the USPTO record | Term ended | Term ended May 16, 2021 | From the USPTO record |
| US 9,631,220 | Method for designing a drug regime for HIV-infected patients Formerly held Lapsed on the fee record Ended Apr 25, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 25, 2021 | From the USPTO record |
| US 8,338,101 | Method for designing a drug regime for HIV-infected patients Lapsed on the fee record Ended Dec 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | From the USPTO record |
| US 6,800,463 | Method for mutation detection in HIV-1 using pol sequencing Term ended Term ended Aug 18, 2020 · From the USPTO record | Term ended | Term ended Aug 18, 2020 | From the USPTO record |
| US 7,977,053 | Circular probe amplification (CPA) using energy-transfer primers Lapsed on the fee record Ended Jul 12, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 12, 2019 | From the USPTO record |
| US 8,790,870 | Quantitative HIV phenotype or tropism assay Lapsed on the fee record Ended Jul 29, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 29, 2018 | From the USPTO record |
| US 6,221,578 | Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains Term ended Term ended Jul 24, 2018 · From the USPTO record | Term ended | Term ended Jul 24, 2018 | From the USPTO record |
| US 7,058,616 | Method and system for predicting resistance of a disease to a therapeutic agent using a neural network Lapsed on the fee record Ended Jun 6, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jun 6, 2018 | From the USPTO record |